Cincinnati, OH, April 30, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (the “Company”) announced that it received ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

Onconetix's low stock price has triggered yet another warning from the Nasdaq. The company plans to request a hearing with the exchange. GE Aerospace CEO unveils ...

— We have everything you need: full data on over 800 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & ...

Onconetix, Inc., a pharmaceutical company with a market capitalization of just $490,000, is facing potential delisting from The Nasdaq Stock Market LLC due to its inability to maintain the minimum bid ...

Onconetix, Inc., a pharmaceutical company with a market capitalization of just $490,000, is facing potential delisting from The Nasdaq Stock Market LLC due to its inability to maintain the minimum ...